Ramelteon as an Adjunct Therapy in Non-Diabetic Patients With Schizophrenia

NCT00595504 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia
Schizoaffective Disorder
Schizophreniform Disorders

Interventions

DRUG: Ramelteon
DRUG: Placebo

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]